CSF2 and neoplasm: To generate recombinant proteins with built-in TLR2 agonists and GM-CSF dual-function activity, we constructed tumor antigens with an N-terminal lipidation signal and fused them to MoGM and a hexahistidine tag at the C-terminus (figure 1A).